Clinical trial
Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active…
NCT00292422 · Biogen, Industry · Completed
Key facts
| NCT number | NCT00292422 |
|---|---|
| Title | Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis |
| Official title | A Randomized, Blinded, Placebo-Controlled, Multicenter, Dose-Escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BG9924 When Given in Combination With Methotrexate to Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to DMARD Therapy |
| Lead sponsor | Biogen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | BG9924 |
| Enrollment | 50 |
| Start date | Nov 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Feb 16, 2006 |
| Last update posted | Dec 31, 2007 |
| Countries | Poland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: